Seers Co., Ltd. (458870) received Canadian medical device approval for its Mobicare heart monitoring system, Yonhap reported Monday. The September 7 company announcement covers the integrated system rather than a single component of the monitoring platform.
Health Canada's authorization includes the wearable electrocardiogram device and electrodes alongside software for both medical institutions and patients. Mobicare combines wearable monitoring with AI analysis of electrocardiogram data, according to the company's account in the report.
Seers had previously received US Food and Drug Administration authorization in June. The company's market capitalisation was ₩0.9 trillion at Monday's close.
kstock reads DART every morning and writes up what moved — the contract, the buyback, the number that does not add up. The daily post and a Saturday roundup, by email.
| Symbol | Last Price |
|---|---|
| 458870Seers Co., Ltd. | ₩22,450 +5.2% |